journal article·2023-11Open access

Bacterial Magnetosome‐Hitchhiked Quick‐Frozen Neutrophils for Targeted Destruction of Pre‐Metastatic Niche and Prevention of Tumor Metastasis

Xiaoqing Han, Xingbo Wang, Jiao Yan, Panpan Song, Yanjing Wang, Chao Shang, Yunyun Wu, Hua Zhang, Zhenxin Wang, Haiyuan Zhang, Xi Li

Advanced Healthcare Materials· Volume 12· Issue 28

Abstract

Abstract Premetastatic niche (PMN) is a prerequisite for tumor metastasis. Destruction of PMN can significantly suppress the tumor metastasis. Bone marrow‐derived cells are usually recruited into the premetastatic organs to support PMN formation, which can be orchestrated by tumor‐derived secreted factors. Neutrophils can chemotactically migrate towards the inflammatory sites and consume tumor‐derived secreted factors, capable of acting as therapeutic agents for a broad‐spectrum suppression of PMN formation and metastasis. However, neutrophils in response to inflammatory signals can release neutrophil extracellular traps (NETs), promoting the tumor metastasis. Herein, live neutrophils are converted into dead neutrophils (CNE) through a quick‐frozen process to maintain PMN‐targeting and tumor‐derived secreted factor‐consuming abilities but eliminate NET‐releasing shortcomings. Considering macrophages‐regulated remodeling of the extracellular matrix in PMN, bacterial magnetosomes (Mag) are further hitchhiked on the surface of CNE to form CNEMag, which can repolarize macrophages from M2 to M1 phenotype for further disruption of PMN formation. A series of in vitro and in vivo assessments have been applied to confirm the effectiveness of CNEMag in suppression of PMN formation and metastasis. This study presents a promising strategy for targeted anti‐metastatic therapy in clinics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immune cells in cancer · Extracellular vesicles in disease

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laboratory of Chemical Biology Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 China

School of Applied Chemistry and Engineering University of Science and Technology of China Hefei Anhui 230026 China

The Key Laboratory of Molecular Epigenetics of Ministry of Education Institute of Genetics and Cytology School of Life Sciences Northeast Normal University Changchun 130024 China

School of Chemistry and Life Science Changchun University of Technology Changchun 130012 China

State Key Laboratory of Electroanalytical Chemistry Changchun Institute of Applied Chemistry Chinese Academy of Sciences Changchun 130022 China

Funding

National Natural Science Foundation of China

References (55)

Show source-provided references
1. 10.1038/nrclinonc.2016.14410.1038/nrclinonc.2016.144 ↗
2. 10.1038/nrc262710.1038/nrc2627 ↗
3. 10.1038/nrc.2016.2510.1038/nrc.2016.25 ↗
4. 10.1038/nature1575610.1038/nature15756 ↗
5. 10.1016/j.ccell.2016.09.01110.1016/j.ccell.2016.09.011 ↗
6. Paget S. · Cancer Metastasis Rev. · 1989 · 8 · 98
7. 10.1158/0008-5472.CAN-06-240710.1158/0008-5472.CAN-06-2407 ↗
8. 10.1038/nrc.2017.610.1038/nrc.2017.6 ↗
9. 10.1038/ncb316910.1038/ncb3169 ↗
10. 10.1158/1078-0432.CCR-16-150810.1158/1078-0432.CCR-16-1508 ↗
11. 10.1158/0008-5472.CAN-11-387310.1158/0008-5472.CAN-11-3873 ↗
12. 10.1002/ijc.3053810.1002/ijc.30538 ↗
13. 10.1021/acs.nanolett.9b0388310.1021/acs.nanolett.9b03883 ↗
14. 10.1021/acs.nanolett.9b0049510.1021/acs.nanolett.9b00495 ↗
15. 10.1016/j.nantod.2022.10159710.1016/j.nantod.2022.101597 ↗
16. 10.1038/s41586-020-2054-x10.1038/s41586-020-2054-x ↗
17. 10.1172/JCI12198510.1172/JCI121985 ↗
18. 10.1038/nri378910.1038/nri3789 ↗
19. 10.3390/cancers1212375210.3390/cancers12123752 ↗
20. 10.1016/j.jconrel.2020.06.03710.1016/j.jconrel.2020.06.037 ↗
21. 10.1038/s41392-020-0165-310.1038/s41392-020-0165-3 ↗
22. 10.1073/pnas.101585510710.1073/pnas.1015855107 ↗
23. 10.1136/gutjnl-2021-32410910.1136/gutjnl-2021-324109 ↗
24. 10.1016/S0002-9440(10)63238-510.1016/S0002-9440(10)63238-5 ↗
25. 10.1038/s41388-019-1084-z10.1038/s41388-019-1084-z ↗
26. 10.1016/j.immuni.2022.07.00110.1016/j.immuni.2022.07.001 ↗
27. 10.1016/j.intimp.2013.06.03410.1016/j.intimp.2013.06.034 ↗
28. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
29. 10.1038/s41467-018-07250-610.1038/s41467-018-07250-6 ↗
30. 10.1371/journal.pone.004811110.1371/journal.pone.0048111 ↗
31. 10.1126/scitranslmed.aag171110.1126/scitranslmed.aag1711 ↗
32. 10.1038/s41586-020-2394-610.1038/s41586-020-2394-6 ↗
33. 10.1126/sciadv.abc301310.1126/sciadv.abc3013 ↗
34. 10.1084/jem.2015119310.1084/jem.20151193 ↗
35. 10.1002/advs.20190019510.1002/advs.201900195 ↗
36. 10.1007/s00262-010-0855-810.1007/s00262-010-0855-8 ↗
37. 10.18632/oncotarget.1706110.18632/oncotarget.17061 ↗
38. 10.1038/onc.2017.11810.1038/onc.2017.118 ↗
39. 10.1038/nnano.2016.16810.1038/nnano.2016.168 ↗
40. 10.1016/j.biomaterials.2019.11951510.1016/j.biomaterials.2019.119515 ↗
41. 10.1002/adma.20180721110.1002/adma.201807211 ↗
42. 10.7150/ntno.3460110.7150/ntno.34601 ↗
43. 10.1016/j.biomaterials.2016.11.02210.1016/j.biomaterials.2016.11.022 ↗
44. 10.1039/C9CC00220K10.1039/C9CC00220K ↗
45. 10.1186/1479-5876-10-15210.1186/1479-5876-10-152 ↗
46. 10.1172/JCI6130310.1172/JCI61303 ↗
47. 10.1073/pnas.180882911510.1073/pnas.1808829115 ↗
48. 10.1186/s13054-021-03775-310.1186/s13054-021-03775-3 ↗
49. 10.1016/j.ccell.2016.06.02110.1016/j.ccell.2016.06.021 ↗
50. 10.1158/0008-5472.CAN-12-199310.1158/0008-5472.CAN-12-1993 ↗
51. 10.1038/ncomms1319310.1038/ncomms13193 ↗
52. 10.1021/acsnano.7b0071510.1021/acsnano.7b00715 ↗
53. 10.1002/adma.20190527110.1002/adma.201905271 ↗
54. 10.1128/AEM.70.2.1040-1050.200410.1128/AEM.70.2.1040-1050.2004 ↗
55. Zhang J. · Mol Cell · 2020 · 50